ArticleScientific reports2025

Two-year results of switching to intravitreal administration of faricimab in patients with aflibercept-refractory neovascular age-related macular degeneration.

Masaaki Saito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.